Are beta‐blockers on the therapeutic horizon for ovarian cancer treatment?

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3380-3383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐selective beta‐blockers may reduce risk of hepatocellular carcinoma: a meta‐analysis of randomized trials

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 2009-2016

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mechanisms of Beta-Blockers Action in Patients with Heart Failure

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 2, 2014-06 ,pp. : 58-60

Bentham Science Publishers

Access to resources Recommend Favorite

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

By Monami Matteo   Filippi Luca   Ungar Andrea   Sgrilli Federica   Antenore Alessandro   Dicembrini Ilaria   Bagnoli Paola   Marchionni Niccolò   Rotella Carlo Maria   Mannucci Edoardo  

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 369-378

Informa Healthcare

Access to resources Recommend Favorite

AchievemenT of target resting HEart rate on beta-blockers in patients with stable angiNA and hypertension (ATHENA) in routine clinical practice in Russia

By Kobalava Zhanna   Khomitskaya Yunona   Kiyakbaev Gayrat    

Current Medical Research and Opinion, Vol. 30, Iss. 5, 2014-05 ,pp. : 805-811

Informa Healthcare

Access to resources Recommend Favorite